HIGH

123Herbals SILINTAN 25-Pill Meloxicam Recall in 2026

123Herbals LLC recalled SILINTAN 25-pill bottles sold nationwide in the United States after FDA analysis found undeclared meloxicam. An NDA/ANDA violation is cited. Consumers and healthcare providers should stop using this product immediately and contact 123Herbals LLC for guidance.

Quick Facts at a Glance

Recall Date
October 20, 2025
Hazard Level
HIGH
AI Risk Assessment
CRITICAL
Brand
123Herbals
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact ANTHONY TRINH, 123Herbals LLC or your healthcare provider for guidance. Notification method: Press Release

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

SILINTAN is marketed as a 25-pill drug bottle by 123Herbals LLC. The product is alleged to be meloxicam-containing and sold in the United States.

Why This Is Dangerous

Undeclared meloxicam in a drug product can cause adverse reactions in people with NSAID sensitivities or those taking interacting medications.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers who purchased SILINTAN face potential health risks. The recall is active and regulatory oversight is ongoing.

Practical Guidance

How to identify if yours is affected

  1. Check if you own SILINTAN 25-pill bottles from 123Herbals.
  2. Look for label that matches SILINTAN with 25 pills per bottle.
  3. Verify there is no NDA/ANDA approved status listed on labeling.

Where to find product info

FDA enforcement report D-0388-2026 at the provided recall page; press release from 123Herbals.

What timeline to expect

Refunds or replacements are not detailed; typical recall processes can take 4-8 weeks.

If the manufacturer is unresponsive

  • Document all communications with the company.
  • Contact FDA or state authorities if the company does not respond.
  • Consider legal consultation for delayed refunds.

How to prevent similar issues

  • Buy medications only from licensed pharmacists or reputable retailers.
  • Verify NDA/ANDA status and labeling before purchase.
  • Check FDA recall notices regularly for updates.

Documentation advice

Keep packaging, labeling, purchase receipts, and all correspondence with the company for records.

Product Details

Model numbers: All lots within expiry Where sold: USA nationwide When sold: Unknown Price: Unknown(USD)

Key Facts

  • Class I recall indicating potential life-threatening risk
  • All lots within expiry affected
  • 25-pill bottle packaging
  • Undeclared meloxicam detected by FDA
  • Distribution: USA nationwide
  • Company: 123Herbals LLC / ANTHONY TRINH

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelCRITICAL
Severity Score
10/ 10
Affected Groups
GENERAL
Injury Types
POISONING

Product Classification

Product Details

Model Numbers
All lots within expiry
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more